SILICON VALLEY – WoundReference has recently become one of only 150 selected companies worldwide to secure a coveted presentation slot at the prestigious 11th annual Venture Summit West. The Silicon Valley-based event connects founders of the hottest venture backed, emerging, and early-stage companies with an exclusive audience of venture capitalists, corporate investors, private investors, investment bankers, and strategic partners.

WoundReference is a leading innovator in clinical, reimbursement and operations decision support platform for wound care. It addresses a US$32 billion problem, representing the annual expenditure on wound care in the United States. Despite this substantial investment, 50% of chronic wounds fail to heal. 

“Chronic wounds are a silent epidemic. They are the leading cause of non-traumatic leg amputations, with a mortality rate worse than most cancers.” explains Elaine Song, CEO, and co-founder of WoundReference. “Our goal is to enhance the standard of care delivered by healthcare institutions by providing knowledge and decision support at the point of care. This approach has proven to achieve significantly better clinical outcomes, while ensuring institutions are working at their most efficient and effective levels.”

The company, selected by youngStartup Ventures as a Top Innovator, will participate at the Venture Summit West, along with other promising companies in tech, AI, fintech, cleantech, medtech, life sciences, and healthcare sectors. With a robust attendance of thousands annually and over 140 distinguished investors with over $250B under management, Venture Summit West serves as the epicenter where significant deals are made. For WoundReference, this represents a wonderful opportunity to engage with potential investors, articulate their vision, and secure the crucial funding necessary to advance their groundbreaking initiatives.

Venture Summit West meticulously selects presenters for the Top Innovators Program based on strict criteria encompassing industry relevance, stage of development, business model, target audience size, milestones achieved to date, and alignment with the interests of featured investors. The program is tailored to emerging growth companies looking to secure series A-C funding ranging from $2-30 million.

About WoundReference:

WoundReference is a wound care-specific clinical, reimbursement and operations decision support platform. It offers subscription plans for healthcare institutions and for wound care and HBOT professionals and has more than 11,000 subscribers from over 3,400 institutions, including 85% of the top US 33 hospitals and 4 EU associations.

Operating since 2017, its co-founders have a deep expertise in wound management, HBOT and reimbursement. The innovative solution has already won twelve international awards from renowned entities such as JWC, SAWC and Wound Care Education Institute.

To learn more about WoundReference visit our website: woundreference.com